Exposure of platelet membrane phosphatidylserine regulates blood coagulation.

This article addresses the role of platelet membrane phosphatidylserine (PS) in regulating the production of thrombin, the central regulatory molecule of blood coagulation. PS is normally located on the cytoplasmic face of the resting platelet membrane but appears on the plasma-oriented surface of discrete membrane vesicles that derive from activated platelets. Thrombin, the central molecule of coagulation, is produced from prothrombin by a complex ("prothrombinase") between factor Xa and its protein cofactor (factor V(a)) that forms on platelet-derived membranes. This complex enhances the rate of activation of prothrombin to thrombin by roughly 150,000 fold relative to factor X(a) in solution. It is widely accepted that the negatively charged surface of PS-containing platelet-derived membranes is at least partly responsible for this rate enhancement, although there is not universal agreement on mechanism by which this occurs. Our efforts have led to an alternative view, namely that PS molecules bind to discrete regulatory sites on both factors X(a) and V(a) and allosterically alter their proteolytic and cofactor activities. In this view, exposure of PS on the surface of activated platelet vesicles is a key regulatory event in blood coagulation, and PS serves as a second messenger in this regulatory process. This article reviews our knowledge of the prothrombinase reaction and summarizes recent evidence leading to this alternative viewpoint. This viewpoint suggests a key role for PS both in normal hemostasis and in thrombotic disease.

[1]  L. Pedersen,et al.  Calcium ion binding to human and bovine factor X. , 1990, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[2]  K. Mann,et al.  Factor Va-membrane interaction is mediated by two regions located on the light chain of the cofactor. , 1994, Biochemistry.

[3]  B. Lentz,et al.  Comparison of the abilities of synthetic and platelet-derived membranes to enhance thrombin formation. , 1985, Thrombosis research.

[4]  Sung-Hou Kim,et al.  Structural basis for chemical inhibition of human blood coagulation factor Xa. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[5]  C. Esmon,et al.  Localization of Phosphatidylserine Binding Sites to Structural Domains of Factor Xa * , 2002, The Journal of Biological Chemistry.

[6]  J. Stenflo,et al.  Conformational change of human prothrombin induced by calcium ions: an X-ray scattering study. , 1980, Biochemistry.

[7]  B. Lentz,et al.  Expression of coagulant activity in human platelets: release of membranous vesicles providing platelet factor 1 and platelet factor 3. , 1985, Thrombosis research.

[8]  J. Hurley,et al.  Crystal structure of the Cys2 activator-binding domain of protein kinase Cδ in complex with phorbol ester , 1995, Cell.

[9]  K. Mann,et al.  The association of coagulation factor Xa and factor Va. , 1991, The Journal of biological chemistry.

[10]  B. Lentz,et al.  Association of factor V activity with membranous vesicles released from human platelets: requirement for platelet stimulation. , 1985, Thrombosis research.

[11]  B. Bouchard,et al.  Platelets, leukocytes, and coagulation , 2001, Current opinion in hematology.

[12]  L. Machesky,et al.  Profilin as a potential mediator of membrane-cytoskeleton communication. , 1993, Trends in cell biology.

[13]  A. D. de Vos,et al.  The Ca2+ ion and membrane binding structure of the Gla domain of Ca-prothrombin fragment 1. , 1994, Biochemistry.

[14]  B. Dahlbäck Human coagluation factor V purification and thrombin-catalyzed activation. , 1980, Journal of Clinical Investigation.

[15]  A. Newton,et al.  Mechanism of Interaction of Protein Kinase C with Phorbol Esters , 1995, The Journal of Biological Chemistry.

[16]  S. Krishnaswamy Prothrombinase complex assembly. Contributions of protein-protein and protein-membrane interactions toward complex formation. , 1990, The Journal of biological chemistry.

[17]  K. Mann,et al.  The kinetics and cofactor dependence of the two cleavages involved in prothrombin activation. , 1983, The Journal of biological chemistry.

[18]  H C Hemker,et al.  The role of phospholipids and factor Va in the prothrombinase complex. , 1980, The Journal of biological chemistry.

[19]  K. Mann,et al.  FLUORESCENCE STUDIES OF THE BINDING OF FACTOR Va TO PHOSPHOLIPID VESICLES , 1988, Thrombosis and Haemostasis.

[20]  K. Mann,et al.  Activation of human prothrombin by human prothrombinase. Influence of factor Va on the reaction mechanism. , 1987, The Journal of biological chemistry.

[21]  A. Newton,et al.  Protein Kinase C: Structure, Function, and Regulation (*) , 1995, The Journal of Biological Chemistry.

[22]  A. Holmgren,et al.  Calcium-dependent interaction between gamma-carboxyglutamic acid-containing and N-terminal epidermal growth factor-like modules in factor X. , 1994, The Journal of biological chemistry.

[23]  P. Devaux,et al.  Static and dynamic lipid asymmetry in cell membranes. , 1991, Biochemistry.

[24]  P. Hogg,et al.  Effects of Ca2+ binding on the protease module of factor Xa and its interaction with factor Va. Evidence for two Gla-independent Ca(2+)-binding sites in factor Xa. , 1993, Journal of Biological Chemistry.

[25]  I. D. Campbell,et al.  Key residues involved in calcium-binding motifs in EGF-like domains , 1991, Nature.

[26]  C. Esmon The subunit structure of thrombin-activated factor V. Isolation of activated factor V, separation of subunits, and reconstitution of biological activity. , 1979, The Journal of biological chemistry.

[27]  A. Tulinsky,et al.  Localization of the Thrombin-binding Domain on Prothrombin Fragment 2* , 1998, The Journal of Biological Chemistry.

[28]  O. Kranenburg,et al.  Lysophosphatidic acid: G-protein signalling and cellular responses. , 1997, Current opinion in cell biology.

[29]  D D Monkovic,et al.  Activation of human factor V by factor Xa and thrombin. , 1990, Biochemistry.

[30]  K. Mann,et al.  Contribution of the heavy and light chains of factor Va to the interaction with factor Xa. , 1994, Biochemistry.

[31]  J. Rosing,et al.  Formation of meizothrombin as intermediate in factor Xa-catalyzed prothrombin activation. , 1986, The Journal of biological chemistry.

[32]  K. Mann,et al.  Prothrombin fragments. Ca2+ binding and activation kinetics. , 1975, The Journal of biological chemistry.

[33]  H Brandstetter,et al.  X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Jesty,et al.  The activation of bovine coagulation factor X. , 1976, Methods in enzymology.

[35]  B. Lentz,et al.  Binding of bovine factor Va to phosphatidylcholine membranes. , 1996, Biophysical journal.

[36]  B. Lentz,et al.  Effects of water soluble phosphotidylserine on bovine factor Xa: functional and structural changes plus dimerization. , 2003, Biophysical journal.

[37]  N. C. Robinson,et al.  Cardiolipin-depleted bovine heart cytochrome c oxidase: binding stoichiometry and affinity for cardiolipin derivatives. , 1990, Biochemistry.

[38]  K. Mann,et al.  Prothrombinase complex assembly. Kinetic mechanism of enzyme assembly on phospholipid vesicles. , 1988, The Journal of biological chemistry.

[39]  P. Sims,et al.  Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. , 1988, The Journal of biological chemistry.

[40]  C M Jackson,et al.  The conversion of prothrombin to thrombin. IV. The function of the fragment 2 region during activation in the presence of factor V. , 1974, The Journal of biological chemistry.

[41]  G. Chacko,et al.  Location of phosphatidylethanolamine and phosphatidylserine in the human platelet plasma membrane. , 1976, The Journal of clinical investigation.

[42]  T. Ortel,et al.  Partial glycosylation at asparagine-2181 of the second C-type domain of human factor V modulates assembly of the prothrombinase complex. , 1999, Biochemistry.

[43]  M. Ullner,et al.  How an epidermal growth factor (EGF)-like domain binds calcium. High resolution NMR structure of the calcium form of the NH2-terminal EGF-like domain in coagulation factor X. , 1994, The Journal of biological chemistry.

[44]  K. Fujikawa,et al.  The mechanism of activation of bovine factor X (Stuart factor) by intrinsic and extrinsic pathways. , 1974, Biochemistry.

[45]  K. Kotkow,et al.  The Second Kringle Domain of Prothrombin Promotes Factor Va- mediated Prothrombin Activation by Prothrombinase (*) , 1995, The Journal of Biological Chemistry.

[46]  J. Nishioka,et al.  Prothrombin kringle 1 domain interacts with factor Va during the assembly of prothrombinase complex. , 1997, The Biochemical journal.

[47]  R. Huber,et al.  Structure of human des(1-45) factor Xa at 2.2 A resolution. , 1993, Journal of molecular biology.

[48]  B. Lentz,et al.  Soluble phosphatidylserine binds to a single identified site in the C2 domain of human factor Va. , 2001, Biochemistry.

[49]  C. Esmon,et al.  Asp-70-->Lys mutant of factor X lacks high affinity Ca2+ binding site yet retains function. , 1994, Journal of Biological Chemistry.

[50]  S. Krishnaswamy,et al.  The activation of prothrombin by the prothrombinase complex. The contribution of the substrate-membrane interaction to catalysis. , 1994, The Journal of biological chemistry.

[51]  C. Esmon,et al.  Loss of prothrombin and of factor Xa-factor Va interactions upon inactivation of factor Va by activated protein C. , 1984, The Journal of biological chemistry.

[52]  K. Mann,et al.  "Clotspeed," a mathematical simulation of the functional properties of prothrombinase. , 1984, The Journal of biological chemistry.

[53]  C. Esmon,et al.  Analysis of the functions of the first epidermal growth factor-like domain of factor X. , 1993, The Journal of biological chemistry.

[54]  B. Lentz,et al.  Cooperative Roles of Factor Va and Phosphatidylserine-containing Membranes as Cofactors in Prothrombin Activation* , 2002, The Journal of Biological Chemistry.

[55]  P. Comfurius,et al.  Changes in membrane phospholipid distribution during platelet activation. , 1983, Biochimica et biophysica acta.

[56]  B. Lentz,et al.  Fluorescence resonance energy transfer study of shape changes in membrane-bound bovine prothrombin and meizothrombin. , 1997, Biochemistry.

[57]  P. Wolf The Nature and Significance of Platelet Products in Human Plasma , 1967, British journal of haematology.

[58]  B. Dahlbäck,et al.  Structural investigation of the A domains of human blood coagulation factor V by molecular modeling , 1998, Protein science : a publication of the Protein Society.

[59]  A. Tulinsky,et al.  Structure of the non-covalent complex of prothrombin kringle 2 with PPACK-thrombin. , 1994, Chemistry and physics of lipids.

[60]  D. Marsh,et al.  Activation of beef-heart cytochrome c oxidase by cardiolipin and analogues of cardiolipin. , 1990, Biochimica et biophysica acta.

[61]  B. Lentz,et al.  Soluble phospholipids enhance factor Xa-catalyzed prothrombin activation in solution. , 1996, Biochemistry.

[62]  J. Rosing,et al.  Meizothrombin, a Major Product of Factor Xa-Catalyzed Prothrombin Activation , 1988, Thrombosis and Haemostasis.

[63]  H. Mott,et al.  The solution structure of the Raf-1 cysteine-rich domain: a novel ras and phospholipid binding site. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[64]  L. van Deenen,et al.  Action of highly purified phospholipases on blood platelets. Evidence for an asymmetric distribution of phospholipids in the surface membrane. , 1977, Biochimica et biophysica acta.

[65]  M. Pusey,et al.  The physical significance of Km in the prothrombinase reaction. , 1983, Biochemical and biophysical research communications.

[66]  Robert Huber,et al.  X-ray Structure of Active Site-inhibited Clotting Factor Xa , 1996, The Journal of Biological Chemistry.

[67]  T. Drakenberg,et al.  Three-dimensional structure of the apo form of the N-terminal EGF-like module of blood coagulation factor X as determined by NMR spectroscopy and simulated folding. , 1992, Biochemistry.

[68]  B. Furie,et al.  The Gla Domain of Human Prothrombin Has a Binding Site for Factor Va* , 2000, The Journal of Biological Chemistry.

[69]  K. Mann,et al.  Identification and characterization of a phospholipid-binding site of bovine factor Va. , 1990, The Journal of biological chemistry.

[70]  K. Mann,et al.  Characteristics of the association between prothrombin fragment 2 and alpha-thrombin. , 1976, Biochemistry.

[71]  B. Lentz,et al.  A new model to describe extrinsic protein binding to phospholipid membranes of varying composition: application to human coagulation proteins. , 1989, Biochemistry.

[72]  A. Aderem,et al.  The myristoyl-electrostatic switch: a modulator of reversible protein-membrane interactions. , 1995, Trends in biochemical sciences.

[73]  A. Tulinsky,et al.  The calcium ion and membrane binding structure of the Gla domain of calcium-prothrombin fragment 1 , 1992 .

[74]  J. Miletich,et al.  Substitution of asparagine for arginine 347 of recombinant factor Xa markedly reduces factor Va binding. , 2000, Biochemistry.

[75]  K. Mann,et al.  The reassociation of factor Va from its isolated subunits. , 1989, The Journal of biological chemistry.

[76]  K. Mann,et al.  Human prothrombinase complex assembly and function on isolated peripheral blood cell populations. , 1985, The Journal of biological chemistry.

[77]  G. Willems,et al.  Production of thrombin by the prothrombinase complex is regulated by membrane-mediated transport of prothrombin. , 1991, The Journal of biological chemistry.

[78]  X. Zhai,et al.  Phosphatidylserine binding alters the conformation and specifically enhances the cofactor activity of bovine factor Va. , 2002, Biochemistry.

[79]  H. Hemker,et al.  Peptide Bond Cleavages and Loss of Functional Activity during Inactivation of Factor Va and Factor VaR506Q by Activated Protein C (*) , 1995, The Journal of Biological Chemistry.

[80]  Y. Hannun,et al.  Ceramide: an intracellular signal for apoptosis. , 1995, Trends in biochemical sciences.

[81]  J. Nishioka,et al.  Blood coagulation factor Xa interacts with a linear sequence of the kringle 2 domain of prothrombin. , 1994, Journal of Biochemistry (Tokyo).

[82]  H. Hemker,et al.  Functional properties of human factor Va lacking the Asp683-Arg709 domain of the heavy chain. , 1994, The Journal of biological chemistry.

[83]  J. Trewhella,et al.  The relative orientation of Gla and EGF domains in coagulation factor X is altered by Ca2+ binding to the first EGF domain. A combined NMR-small angle X-ray scattering study. , 1996, Biochemistry.

[84]  M. Roberts,et al.  Allosteric activation of phosphatidylinositol-specific phospholipase C: specific phospholipid binding anchors the enzyme to the interface. , 1997, Biochemistry.

[85]  S. Forsén,et al.  Structure of the Ca2+-free GLA domain sheds light on membrane binding of blood coagulation proteins , 1995, Nature Structural Biology.

[86]  Role of procoagulant lipids in human prothrombin activation. 2. Soluble phosphatidylserine upregulates and directs factor X(a) to appropriate peptide bonds in prothrombin. , 2002, Biochemistry.

[87]  B. Lentz,et al.  Phosphatidylserine-containing membranes alter the thermal stability of prothrombin's catalytic domain: a differential scanning calorimetric study. , 1994, Biochemistry.

[88]  S. Fleischer,et al.  Cooperativity in lipid activation of 3-hydroxybutyrate dehydrogenase: role of lecithin as an essential allosteric activator. , 1989, Biochemistry.

[89]  S. Linse,et al.  Calcium binding to the isolated beta-hydroxyaspartic acid-containing epidermal growth factor-like domain of bovine factor X. , 1989, The Journal of biological chemistry.

[90]  A. Schroit,et al.  Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of aminophospholipid translocase. , 1990, Biochimica et biophysica acta.

[91]  V. Bloomfield,et al.  Structure of the prothrombin- and blood clotting factor X-membrane complexes. , 1977, Biochemistry.

[92]  K. Mann,et al.  The contribution of bovine Factor V and Factor Va to the activity of prothrombinase. , 1979, The Journal of biological chemistry.

[93]  J. Stenflo,et al.  The gamma-carboxyglutamic acid and epidermal growth factor-like domains of factor X. Effect of isolated domains on prothrombin activation and endothelial cell binding of factor X. , 1991, Journal of Biological Chemistry.

[94]  M. Olson,et al.  Platelet-activating factor: receptors and signal transduction. , 1993, The Biochemical journal.

[95]  C. Esmon,et al.  New insights into the regulation of the blood clotting cascade derived from the X-ray crystal structure of bovine meizothrombin des F1 in complex with PPACK. , 1997, Structure.

[96]  D. Monroe,et al.  Platelets and thrombin generation. , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[97]  B. Lentz,et al.  Role of procoagulant lipids in human prothrombin activation. 1. Prothrombin activation by factor X(a) in the absence of factor V(a) and in the absence and presence of membranes. , 2002, Biochemistry.

[98]  K. Mann,et al.  Insights into the complex association of bovine factor Va with acidic-lipid-containing synthetic membranes. , 1996, Biophysical journal.

[99]  A. Tulinsky,et al.  Interaction of Calcium with Native and Decarboxylated Human Factor X. , 1997, The Journal of Biological Chemistry.

[100]  A. Giles,et al.  Studies of the role of factor Va in the factor Xa-catalyzed activation of prothrombin, fragment 1.2-prethrombin-2, and dansyl-L-glutamyl-glycyl-L-arginine-meizothrombin in the absence of phospholipid. , 1990, The Journal of biological chemistry.

[101]  X. Zhai,et al.  Soluble Phosphatidylserine Triggers Assembly in Solution of a Prothrombin-activating Complex in the Absence of a Membrane Surface* , 2002, The Journal of Biological Chemistry.

[102]  G. Willems,et al.  Assembly of the prothrombinase complex on lipid vesicles depends on the stereochemical configuration of the polar headgroup of phosphatidylserine. , 1994, Biochemistry.

[103]  R. Huber,et al.  Crystal structures of the membrane-binding C2 domain of human coagulation factor V , 1999, Nature.